isunakinra (EBI-005) - Sesen Bio
Eleven Biotherapeutics: Q3 FY 2015 Results (Eleven Biotherapeutics) - Nov 6, 2015 - Anticipated data from truncated safety P3 study (NCT02405039) in dry eye disease in Q1 2016 
Anticipated P3 data • Immunology
http://seekingalpha.com/article/3643806-eleven-biotherapeutics-ebio-ceo-dr-abbie-celniker-on-q3-2015-results-earnings-call-transcript
 
Nov 6, 2015
 
.